Valluvan Jeevanandam to Hemorrhage
This is a "connection" page, showing publications Valluvan Jeevanandam has written about Hemorrhage.
Connection Strength
0.753
-
Optimal haemodynamics during left ventricular assist device support are associated with reduced haemocompatibility-related adverse events. Eur J Heart Fail. 2019 05; 21(5):655-662.
Score: 0.136
-
Laparoscopic procedures in patients with cardiac ventricular assist devices. Surg Endosc. 2019 07; 33(7):2181-2186.
Score: 0.135
-
Increased Risk of Bleeding in Left Ventricular Assist Device Patients Treated with Enoxaparin as Bridge to Therapeutic International Normalized Ratio. ASAIO J. 2018 Mar/Apr; 64(2):140-146.
Score: 0.129
-
Tumor necrosis factor-a levels and non-surgical bleeding in continuous-flow left ventricular assist devices. J Heart Lung Transplant. 2018 01; 37(1):107-115.
Score: 0.122
-
Increased activation of the coagulation and fibrinolytic systems leads to hemorrhagic complications during left ventricular assist implantation. Circulation. 1996 Nov 01; 94(9 Suppl):II227-34.
Score: 0.117
-
Elevated Angiopoietin-2 Level in Patients With Continuous-Flow Left Ventricular Assist Devices Leads to Altered Angiogenesis and Is Associated With Higher Nonsurgical Bleeding. Circulation. 2016 Jul 12; 134(2):141-52.
Score: 0.114